377 related articles for article (PubMed ID: 32188044)
1. Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats.
Feige J; Moser T; Bieler L; Schwenker K; Hauer L; Sellner J
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32188044
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D and multiple sclerosis: review of a possible association.
Summerday NM; Brown SJ; Allington DR; Rivey MP
J Pharm Pract; 2012 Feb; 25(1):75-84. PubMed ID: 21987526
[TBL] [Abstract][Full Text] [Related]
3. The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis.
James E; Dobson R; Kuhle J; Baker D; Giovannoni G; Ramagopalan SV
Mult Scler; 2013 Oct; 19(12):1571-9. PubMed ID: 23698130
[TBL] [Abstract][Full Text] [Related]
4. Canadian recommendations for vitamin D intake for persons affected by multiple sclerosis.
Atkinson SA; Fleet JC
J Steroid Biochem Mol Biol; 2020 May; 199():105606. PubMed ID: 31981800
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial.
Dörr J; Ohlraun S; Skarabis H; Paul F
Trials; 2012 Feb; 13():15. PubMed ID: 22316314
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of vitamin D in multiple sclerosis: A meta-analysis.
Zheng C; He L; Liu L; Zhu J; Jin T
Mult Scler Relat Disord; 2018 Jul; 23():56-61. PubMed ID: 29778041
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory effects and therapeutic potential of vitamin D in multiple sclerosis.
Yeh WZ; Gresle M; Jokubaitis V; Stankovich J; van der Walt A; Butzkueven H
Br J Pharmacol; 2020 Sep; 177(18):4113-4133. PubMed ID: 32668009
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and multiple sclerosis: An update.
Pierrot-Deseilligny C; Souberbielle JC
Mult Scler Relat Disord; 2017 May; 14():35-45. PubMed ID: 28619429
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
Smolders J; Hupperts R; Barkhof F; Grimaldi LM; Holmoy T; Killestein J; Rieckmann P; Schluep M; Vieth R; Hostalek U; Ghazi-Visser L; Beelke M;
J Neurol Sci; 2011 Dec; 311(1-2):44-9. PubMed ID: 21620416
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D for the management of multiple sclerosis.
Jagannath VA; Fedorowicz Z; Asokan GV; Robak EW; Whamond L
Cochrane Database Syst Rev; 2010 Dec; (12):CD008422. PubMed ID: 21154396
[TBL] [Abstract][Full Text] [Related]
11. The effects of vitamin D supplementation on expanded disability status scale in people with multiple sclerosis: A critical, systematic review and metaanalysis of randomized controlled trials.
Doosti-Irani A; Tamtaji OR; Mansournia MA; Ghayour-Mobarhan M; Ferns G; Daneshvar Kakhaki R; Rezaei Shahmirzadi A; Asemi Z
Clin Neurol Neurosurg; 2019 Dec; 187():105564. PubMed ID: 31669929
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D supplementation for cystic fibrosis.
Ferguson JH; Chang AB
Cochrane Database Syst Rev; 2014 May; (5):CD007298. PubMed ID: 24823922
[TBL] [Abstract][Full Text] [Related]
13. A Brief Review of the Effects of Vitamin D on Multiple Sclerosis.
Miclea A; Bagnoud M; Chan A; Hoepner R
Front Immunol; 2020; 11():781. PubMed ID: 32435244
[TBL] [Abstract][Full Text] [Related]
14. [Impact of vitamin D in neurological diseases and neurorehabilitation: from dementia to multiple sclerosis. Part I: the role of vitamin D in the prevention and treatment of multiple sclerosis].
Speer G
Ideggyogy Sz; 2013 Sep; 66(9-10):293-303. PubMed ID: 24358684
[TBL] [Abstract][Full Text] [Related]
15. [The role of vitamin D in multiple sclerosis].
Kfoczyńska M; Kucharska A; Sińska B
Postepy Hig Med Dosw (Online); 2015 Apr; 69():440-6. PubMed ID: 25897104
[TBL] [Abstract][Full Text] [Related]
16. VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial.
Courbebaisse M; Alberti C; Colas S; Prié D; Souberbielle JC; Treluyer JM; Thervet E
Trials; 2014 Nov; 15():430. PubMed ID: 25376735
[TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial.
Kampman MT; Steffensen LH; Mellgren SI; Jørgensen L
Mult Scler; 2012 Aug; 18(8):1144-51. PubMed ID: 22354743
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.
Faridar A; Eskandari G; Sahraian MA; Minagar A; Azimi A
Acta Neurol Belg; 2012 Dec; 112(4):327-33. PubMed ID: 22767049
[TBL] [Abstract][Full Text] [Related]
19. Seasonal, gestational and postnatal influences on multiple sclerosis: the beneficial role of a vitamin D supplementation during early life.
Fernandes de Abreu DA; Landel V; Féron F
J Neurol Sci; 2011 Dec; 311(1-2):64-8. PubMed ID: 21930286
[TBL] [Abstract][Full Text] [Related]
20. An Update on Vitamin D and Disease Activity in Multiple Sclerosis.
Smolders J; Torkildsen Ø; Camu W; Holmøy T
CNS Drugs; 2019 Dec; 33(12):1187-1199. PubMed ID: 31686407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
